Management Using the Latest Technologies in Resource-limited Settings to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE)
Latest Information Update: 09 May 2024
At a glance
- Drugs Atazanavir/ritonavir (Primary) ; Darunavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Etravirine (Primary) ; Lopinavir/ritonavir (Primary) ; Raltegravir (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms MULTI-OCTAVE
- 13 Oct 2023 According to Janssen Pharmaceuticals media release, Janssen Pharmaceuticals has changed its name to Johnson & Johnson Innovative Medicine.
- 06 Apr 2021 Results of sub analysis from cohort A, evaluating associations between antiretroviral hair concentrations, self-reported adherence, and subsequent virologic outcomes, published in the AIDS
- 10 Jul 2020 Results presented at the 23rd International AIDS Conference